Objectives: We aimed to perform a systematic review of all studies with direct measurements of both airway inflammation and remodeling in the subgroup of children with repeated wheezing and/or persistent asthma severe enough to warrant bronchoscopy, to address whether airway inflammation precedes remodeling or is a parallel process, and also to assess the impact of remodeling on lung function.
membrane (RBM), goblet cell hyperplasia, airway smooth muscle (ASM) hypertrophy and hyperplasia, and angiogenesis. 3 The relationship between airway inflammation and airway remodeling is controversial. 4 It should be noted that remodeling is not one entity but multifaceted (above). Potential hypotheses (and different hypotheses may apply to the different components of remodeling) are (1) repeated cycles of acute and acute on chronic airway inflammation are the early events that lead eventually to airway remodeling; (2) airway inflammation and remodeling are parallel processes triggered by the same underlying problem but progress independently; (3) the primary disorder is airway repair and inflammation is secondary to abnormal repair processes; and (4) although remodeling is thought to be damaging, there is at least some evidence that it may be a protective response, for example limiting bronchoconstriction, 5 and possibly also limiting systemic absorption of inflammatory mediators from the airway lumen. The clinical importance of confirming or refuting these hypotheses is that if elements of remodeling are protective, treatment strategies should be aimed at augmenting them, whereas if harmful, the contrary strategy, namely trying to ameliorate the changes, is appropriate.
Since today there is not an indirect measure for inflammation available, here we report a systematic review, using only those published papers where direct measurements of both airway inflammation and/or remodeling (eg, by bronchial alveolar lavage and bronchial biopsy), were made in the subgroup of children with repeated wheezing and/or persistent asthma sufficiently severe to merit bronchoscopy, to try to differentiate between these fundamentally different hypotheses.
| METHODS
We identified published studies in MEDLINE, EMBASE, CINAHL, and SCOPUS (up to June 2017) database, using the terms:
"((bronchoalveolar lavage) OR (airway biopsy) OR (bronchial biopsy)) AND ((wheeze) OR (asthma)) AND ((airway inflammation or airway remodeling))" restricted to child (birth to 18 years old), without language restriction. Studies published solely in abstract form were excluded because the methods and results could not be fully analyzed.
To be included, studies had to meet all of the following criteria:
(1) cross-sectional or cohort studies of airway inflammation and/or remodeling measured directly by bronchoalveolar lavage and/or biopsy in children with asthma or recurrent wheezing; (2) inclusion of children (1-18 years) or in a mixed population (adults and children)
only when children were analyzed separately; (3) experimental or intervention studies. Those studies in which markers of inflammation and remodeling were only measured in blood, urine, saliva or sputum, exhaled breath condensate, lung function or imaging were excluded unless a concomitant bronchoalveolar lavage or endobronchial biopsy were performed for comparison. Autopsy studies, reviews and letters to the editor (without data reports) were also excluded. 
| Data extraction and assessment of risk of bias

| RESULTS
Five hundred and twenty-six studies were retrieved from the databases, of which 39 were eligible for inclusion ( Figure 1 ). Most (n = 33) came from Europe (UK = 16, France = 8, Italy = 3, UK and
Czech Republic = 1, UK and Finland = 1, Czech Republic = 1, the Netherlands = 1, Turkey = 1, and Ireland = 1); there were three studies from United States, two from Australia, and one from Korea. Most studies were case-control (n = 11), cross-sectional (n = 12), and prospective cohort (n = 11); others were case series (n = 3) and retrospective cohorts (n = 2). See Table 1 .
There were 2390 children included in the 39 studies. In 14 studies [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] 20 (n = 637) the population was school age children with a clinical diagnosis of asthma (mainly "difficult to treat" or "severe asthma"), nine studies [22] [23] [24] [25] [26] [27] [28] [29] [30] were exclusively in infants or preschoolers under the age of 5 years with severe recurrent wheezing (n = 409). Fourteen studies [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] combined pre-schoolers and school-aged children (n = 1252). Two studies 45, 46 combined asthmatic children and adults, for this review we only included data from the children (n = 92). Only 11 studies [13] [14] [15] [16] [17] [18] 20, 23, 28, 41, 43 recorded the age of onset of asthma, which varied from 5 months to 11 years.
Thirty-two studies evaluated atopy in their patients. In 27 studies [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] 20, 23, 24, 28, 31, 32, [34] [35] [36] [38] [39] [40] [44] [45] [46] this was by skin prick test, or specific IgE or total IgE; while in seven studies 22, 26, 27, 37, [41] [42] [43] atopy was evaluated by total IgE or clinically; and in three studies only on clinical criteria. 25, 29, 30 Sixteen studies 9, [12] [13] [14] [15] [16] 18, [23] [24] [25] [26] [27] 29, 31, 45 recorded the presence of previous asthma attacks. Twenty-nine studies recorded current asthma medications. 3, [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] 18, 20, [24] [25] [26] [27] [29] [30] [31] [33] [34] [35] 37, 38, 41, [43] [44] [45] Fourteen studies 9, 25, 28, 30, [34] [35] [36] 38, 39, [42] [43] [44] had a control group defined as non-asthmatic/wheezing children (two also included adults 45, 46 ); in 11 studies 11, 13, 15, 16, 20, 24, 31, 32, 37, 40, 41 there was no control group; in six studies 6, 8, 10, 23, 26, 27 the control group was defined as upper airways symptoms; in six studies 12, 14, 17, 18, 29, 33 the control group was defined as lower respiratory problems but nonasthma; and one study 22 compared children that in the future 12 and in both 6, 8, 9 ); while eosinophilic cationic protein (ECP) in BAL was elevated in three studies, 13, 38, 44 but not in one. 43 In contrast, only one study (median aged 14.5 months) 37 reported more BAL neutrophilic inflammation than controls. Mixed eosinophilic and neutrophilic inflammation was reported in BAL in four studies, 6, 9, 30, 45 and also in the submucosa or intraepithelial in three. 6, 9, 16 One study reported significantly more BAL neutrophilic inflammation in pre-schoolers with severe recurrent wheezing compared with more eosinophilic inflammation in school-age severe asthmatics. 31 One study showed that eosinophilic inflammation and remodeling were still present in children who had apparently outgrown asthma. 42 See Table 1 .
| Airway remodeling
Airway remodeling was directly assessed from endobronchial biopsy in 27 studies. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [22] [23] [24] 27, 28, [32] [33] [34] [35] [36] 40, 41, 46 The main finding was increased thickness of the RBM in asthmatics compared to controls 5, 12, 14, 17, 18, 27, 33 ; but with normal ultrastructure (ratio of fibril to matrix). 46 The RBM was thicker and ASM area greater in school children with severe asthma compared with controls 10 and with preschoolers, 32 and vascularity was higher in younger preschoolers than in older. 32 The only study which compared adults and children 18 reported that the RBM thickness of school-age children with difficult asthma was similar to that seen in adults with either mild intermittent or acute life-threatening asthma. In one study, children (median age 13.5 months) 22 who later developed asthma (by a positive API 47 ) already had increased RBM thickening, but not tenascin deposition, than those with negative API; however, no data on inflammatory cells were (Continues) reported. One study 23 reported that increased preschool ASM areabut not RBM thickness, mucosal eosinophils, or ASM mast cells-was seen in children who had asthma at school age. Preschool ASM biopsy proportion of greater than 10% had similar negative predictive value but improved positive predictive value of future asthma compared to a positive API. 47 Finally, increased epithelial shedding in asthmatic children compared to controls was reported in one study, 36 but not in two others. 8, 9 See Table 1 .
In only seven studies 6, 8, 15, 16, 32, 33, 40 were both airway inflammation and remodeling measured simultaneously. In terms of inflammatory cells, one study 8 demonstrated eosinophilic inflammation in association with remodeling; one study 32 reported no differences in BAL cytology compared with controls, but more submucosal eosinophils in the biopsies; and in another study 6 there was BAL eosinophilia while intraepithelial neutrophils were present in the bronchial biopsies. However, in all studies in which airway remodeling and inflammation were simultaneously reported, inflammation (mainly eosinophilic) co-existed with remodeling.
| Subgroup analysis by age and control groups
Paediatric studies that have made direct assessments of airway pathology in wheeze/asthma can be divided into three groups. (1) Studies exclusively in school-age asthmatics compared with controls (defined by the presence of upper airway symptoms) which have shown significantly more BAL eosinophils, 23 EPC and tryptase, 38 subepithelial eosinophils, 17 mucosal eosinophils, 6 intraepithelial neutrophils, 6 and submucosal and epitelhial IL-17RA-positive cells. 6 There were also studies that reported significantly increased RBM thickness, 8, 17, 33 hypertrophy and hyperplasia of ASM, 8, 10 but not epithelial sheeding, 8 and decreased expression of TGFβ-RII, 17 in asthmatic. (2) Studies exclusively in school-age asthmatics compared with controls (defined by the presence of lower respiratory symptoms, but not asthma) have reported more mucosal eosinophils, 41 and significantly increased RBM thickness, 12, 14, 41 in asthmatic. (3) Studies exclusively in preschoolers have reported higher BAL eosinophils, 25 neutrophils, 30 in wheezers compared to non-wheezers. There were higher BAL MMP-9/TIMP-1 ratio in wheezers than controls, 26 a significant increase in the BAL CD8+ lymphocyte population and decreased expression of HLA-DR in the macrophage population in wheezers as compared to non-wheezers, 29 and significantly higher BAL eosinophils, neutrophils, lymphocytes, epithelial cells, LTE4, LTB4, PGE2, 15-HETE in persistent wheezers compared to controls. 30 Those with confirmed wheezing had greater RBM thickness 27 and eosinophil density 27 than controls. RBM thickness and eosinophilic inflammation, characteristics of asthma in older children and adults, were not present in symptomatic infants (mean age 1 year) with reversible airflow obstruction, even in the presence of atopy. 28 
| Subgroup analysis by atopy
No difference in RBM thickness was reported between atopic and nonatopic severe pre-school wheezers. 27, 34 However, in school age children with severe therapy resistant asthma, RBM thickness was significantly higher in atopic compared to non-atopic patients. 8 ASM area was larger in atopic compared to non-atopic preschool wheezers. 32 Epithelial shedding, RBM thickness, angiogenesis, eosinophilia, and expression of IL-4 and IL-5 were also present to a similar degree in non-atopic and atopic children with multitrigger wheeze. 36 Subepithelial eosinophilic inflammation was similar in atopic and nonatopic confirmed preschool wheezers. 27 No differences in BAL ECP levels was found between atopic and non-atopic asthmatic children. 43 MMP-9 was increased in both atopic and nonatopic preschool wheezers. 26 However, significantly more mast cell tryptase positive cells were present in the lamina propria in atopic compared to non-atopic asthmatics. 41 
| Correlation with other biomarkers
We looked for correlations between airway inflammation and remodeling with other biomarkers, including radiological imaging. ). There was no association between FeNO and airway inflammation, 14 presumably related to the high levels of treatment prescribed for patients undergoing clinically indicated bronchoscopy. 19 Exhaled breath condensate cysteinyl leukotrienes were measured in one study and significantly correlated with RBM thickness (r = 0.75). 40 The value of HRCT-scanning was evaluated in only one study, 13 reporting a significant correlation between CT measures of airway wall and direct measurement of RBM thickness (r = 0.34). Lung function, mainly spirometry, was measured in 23 studies, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] 20, 23, 24, 28, [33] [34] [35] 38, 40, 41, 45, 46 but was significantly correlated in only seven 6, [10] [11] [12] 14, 33, 38 ; for example, and r = −0.61, respectively), 14 and between bronchodilator reversibility and ASM (r = 0.66). 10 Respiratory system resistance was higher in asthmatics with detectable BAL ECP. 38 A direct correlation was found between intraepithelial neutrophils and FEV1 % predicted (r = 0.43). 6 There were no reports comparing sputum or urinary biomarkers with BAL or airway biopsy.
| DISCUSSION
In this systematic review of 39 studies (n = 2390 children) on airway inflammation and remodeling in asthmatic children under 18 years of age, we found that airway inflammation and remodeling was not present at a mean of 12 months of age, but in older pre-school children (mean 2.5 years), remodeling (mainly increased RBM thickness) and airway eosinophilia was reported, especially in the oldest children. However, most of the children studied had been prescribed anti-inflammatory medications, usually inhaled corticosteroids (ICS), and it is likely that, had it been ethical to stop their treatment, inflammation would have been more prominent.
However, some studies found no differences in RBM, 27 ASM, 10 or BAL cellularity 10, 30 when comparing asthmatics who were and were not prescribed ICS. There is no study reporting eosinophilic inflammation without remodeling being present; conversely, the presence of remodeling with no eosinophilic inflammation most likely reflects the anti-inflammatory effects of ICS, and cannot be taken as evidence that remodeling precedes inflammation.
The ideal study to determine the relationship between the onset of symptoms and the progression of airway inflammation and remodeling would be to undertake bronchoscopy with BAL and airway biopsy in high risk children (eg, parental history of asthma/ atopy or positive API) before the onset of symptoms, repeating this test frequently over time. For obvious ethical reasons this is not possible, and we have to draw inferences from inevitably suboptimal studies. We know that symptoms precede inflammation and remodeling 28 ; and we know that remodeling and eosinophilic inflammation may be present with no symptoms in young people who may have outgrown asthma. 21 Only one study 22 demonstrated that remodeling is present before a diagnosis of asthma was made, but these children had significant symptoms at the time of bronchoscopy, and it could be argued that with retrospect, asthma should have been diagnosed much earlier. Taken together, the literature supports the view that at the inception of respiratory symptoms the airway is normal; from age 1 year to school age, remodeling and inflammation develop in parallel; from school age, remodeling is stable, whereas inflammation continues unabated; and inflammation and remodeling persist even in those whose symptoms have resolved.
In the present review, failure to demonstrate eosinophilic inflammation in the setting of a non-remodeled airway would not support the hypothesis that eosinophilic inflammation causes remodeling. Indeed, airway inflammation is ongoing into adult life, whereas at least some aspects of remodeling, such as RBM thickness, are nonprogressive, 18 although in the first years of life, the processes seem to go in parallel. 27, 28 There are some data from adult studies which are informative. In an experimental study performed in adults with mild asthma, repeated methacholine-induced bronchoconstriction can cause remodeling (increased sub-epithelial collagen deposition, increased periodicacid Schiff staining) without inducing airway inflammation. 48 In this context, it is interesting to note the three paediatric studies which have measured AHR shortly after birth, before the onset of infection or inflammation. [49] [50] [51] AHR, presumably as a result of anatomical changes, 52 is associated with long-term adverse respiratory outcomes 50, [53] [54] [55] ; although the pathological correlates of this are unknown, and hence whether in reality in infants, AHR drives remodeling. Segmental allergen challenge in adults is also associated with upregulation of expression of mediators associated with remodeling 56 ; however, this effect appeared to be independent of an airway eosinophilic response 57 and in any case the relevance of acute changes to chronic remodeling is difficult to determine.
Hence we cannot confirm or refute any of the three hypotheses as to the relationship between inflammation and remodeling, but the balance of evidence (at least in pre-clinical models) is that airway inflammation and remodeling are parallel processes, as was demonstrated in a murine model. 58 In that study using a neonatal murine model with intranasal house dust mite challenge, airway responsiveness, airway remodeling and eosinophillic inflammation developed in parallel. 58 Interestingly, among those seven studies where airway inflammation and remodeling were simultaneously measured, there was no single study were remodeling was present in absence of inflammation. Currently, no studies in patient with asthma have been able to determine whether some aspects of airway remodeling in may be protective or deleterious.
We could find two autopsy studies in the literature. Similarly to our findings, in a recent study 59 airways of 12 fatal cases of childhood (mean age of death of 3.1 years) and adolescent asthma were compared with eight controls showed significantly thickened RBM and eosinophil inflammation than controls; but ASM% was increased only in one-third of fatal asthma cases, exclusively in large airways. Large airway ASM% increased with age and correlated with RBM and duration of asthma. A much older study 60 reported results from four children, two lung biopsies and two autopsies, with similar findings.
Lung tissue showed eosinophilic inflammation and reticular basement membrane thickening.
The obvious weakness of this systematic review is the absence of the definitive study in the literature (above). Another problem is that, whereas there numerous surrogates for airway inflammation, including induced sputum, FeNO and peripheral blood eosinophil count, there are no real non-invasive surrogates for remodeling. Urinary desmosine has been proposed, but changes are not closely related to airway remodeling, and CT measurements of airway wall thickness in children were disappointing. 61 Possibly newer imaging technics, for example, magetic resonance imaging with inhalation of hyperpolorized gas, molecular oxygen, and fluorinated gas will be of more use. 62 A pilot study suggested exhaled breath condensate cysteneyl leukotriene and RBM thickness has a significant relationship in the subgroup of children who were not treated with montelukasts 40 Another weakness is the paucity of studies which analyzed more parameters of airway remodeling than RBM thickness or ASM volume.
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Airway remodeling is an umbrella term comprising many components which may have different pathways, and conclusions may be different for different parameters. Also, the subgroup analysis in age less than 1-2 years of age relies on a single study. Furthermore, children with only mild and moderate wheezing syndromes are unlikely to come to bronchoscopy, and our conclusions are only applicable to the subgroup with really severe symptoms.
It is unclear whether epithelial desquamation in endobronchial biopsies in asthmatic children is an artefact of tissue sampling or a true pathologic feature of asthma. In small biopsies in particular mechanical force may affect the tissues during collection and processing. 63 We found only three studies, 8, 9, 36 reporting epithelial shedding, and in one increased epithelial shedding was found in asthmatics compared to controls. 36 In summary, this systematic review has failed to identify data to elucidate the relationship between inflammation and remodeling in children with wheezing/asthma. If the relationship between inflammation and remodeling is to be resolved, a key research priority is to identify reliable non-invasive measurements of inflammation and remodeling that can be used at all ages, including infants and preschool children. This would allow longitudinal assessments and enable us to determine which if any aspects of remodeling are protective and should be augmented, and which worsen airflow obstruction and should be treated.
